Bioventus BVS
NASDAQ BVS
$14.24 -0.44 (-3.00%)
At close: Aug 20, 2026 · 2:21 PM UTC

Bioventus (BVS) Net Margin Growth (3y) (2023 - 2026)

Bioventus (BVS) Net Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Net Margin Growth (3y) (Qtr)
1 Abbott Laboratories 199.49 Bn 193.88 Bn 7.27 Bn -641.00
2 Stryker 127.80 Bn 124.32 Bn 4.50 Bn 459.00
3 Medtronic 118.98 Bn 109.76 Bn 6.41 Bn -108.00
4 Boston Scientific 73.58 Bn 73.04 Bn 3.85 Bn 941.00
5 Edwards Lifesciences 51.93 Bn 47.68 Bn 1.35 Bn -1,024.00
6 Dexcom 34.34 Bn 32.39 Bn 830.00 Mn 574.00
7 GE HealthCare Technologies 33.76 Bn 31.66 Bn 2.18 Bn 216.00
8 Koninklijke Philips 26.37 Bn 23.05 Bn 4.55 Bn 647.00
9 Steris 23.07 Bn 22.59 Bn 684.20 Mn 300.00
10 Bioventus 966.46 Mn 937.00 Mn 105.67 Mn 2,708.00

Historic Data

Download Data
DateValue
Mar 28, 2026 6,550.00
Dec 31, 2025 2,956.00
Sep 27, 2025 3,760.00
Jun 28, 2025 648.00
Mar 29, 2025 -234.00
Apr 1, 2023 -7,585.00